Pharma + healthcare

1
Disputes

Sankyo-Daiichi's move to block Fortis's sale surprised us: Fortis chairman Ravi Rajagopal

When Malaysia’s IHH Healthcare Berhad won the bid for Fortis, the hospital chain expected an end to months of turmoil. Its relief was short-lived. Daiichi Sankyo, the Japanese firm that is fighting an arbitration battle related to Ranbaxy against Shivinder and Malvinder Singh — former promoters of both Ranbaxy and Fortis — wants the Delhi High Court to block Fortis’s sale. In his first interview after being appointed chairman, Ravi Rajagopal opens up about this unexpected hurdle and what it means for Fortis’s future.

[[^message]]

Result

[[/message]] [[#message]]

[[message]]

[[/message]]